Namely, to address sample sizes constraints, we combined some diagnostic subgroups based on previous evidence reporting no significant differences in pTau217 concentrations—namely, PDD and DLB were analyzed together as Lewy Body disorders (5, 15), while CBS (n = 4) was grouped with PSP (16). This evidence concerns the gene CBS and supranuclear palsy, progressive, 1.